--- title: EMTT for Musculoskeletal Disorders description: CuraMedix is pleased to announce the arrival and U.S. debut of the new EMTT(R) (Extracorporeal Magnetotransduction Technology) device, the MAGNETOLITH, powered by STORZ Medical. image: https://www.curamedix.com/hubfs/MAGNETOLITH-CuraMedix_Blog.png --- - [CuraMedix Providers: Insiders' Exchange Login](https://www.curamedix.com/partner-portal-login-page) - ** [![curamedix_logo_color](https://www.curamedix.com/hubfs/Website%202019/Logos/curamedix_logo_color.svg "curamedix_logo_color")](https://www.curamedix.com) [![curamedix_logo_color](https://www.curamedix.com/hubfs/Website%202019/Logos/curamedix_logo_color.svg "curamedix_logo_color")](https://www.curamedix.com) **Redefine Patient Care** Is your practice leading the way with innovative treatment options? #### Featured Resource What is shockwave and what makes it so effective? “The Art of Shockwave” white paper reveals the in-depth science behind the technology. [![Dig in Now](https://no-cache.hubspot.com/cta/default/4232994/0ad47fe2-5d69-4482-acea-98c31886035b.png)](https://cta-redirect.hubspot.com/cta/redirect/4232994/0ad47fe2-5d69-4482-acea-98c31886035b) **Tackle Pain and Aesthetic Concerns FAST** Learn about non-surgical, low-risk treatment options that allow you to stay active. #### Find an EPAT Physician Near You Need help finding a physician near you who offers EPAT as a treatment option? We’ll help connect you right now. [![Find a Physician](https://no-cache.hubspot.com/cta/default/4232994/658a0b27-d683-41b0-8080-9140bc8d848a.png)](https://cta-redirect.hubspot.com/cta/redirect/4232994/658a0b27-d683-41b0-8080-9140bc8d848a) **Cutting-Edge Solutions** Set your practice apart by offering the regenerative solutions your patients are seeking. **Knowledge is Power** It's all right here — go ahead and access clinical evidence, testimonials, Level 10 books and more. #### Featured Resource What is shockwave and what makes it so effective? “The Art of Shockwave” white paper reveals the in-depth science behind the technology. [![Dig in Now](https://no-cache.hubspot.com/cta/default/4232994/0ad47fe2-5d69-4482-acea-98c31886035b.png)](https://cta-redirect.hubspot.com/cta/redirect/4232994/0ad47fe2-5d69-4482-acea-98c31886035b) ## [CuraMedix Blog](https://www.curamedix.com/blog) # CuraMedix Unveils the New MAGNETOLITH November 24, 2020  |  By [Elise Hamann](https://www.curamedix.com/blog/author/elise-hamann) ![MAGNETOLITH-CuraMedix_Blog](https://www.curamedix.com/hs-fs/hubfs/MAGNETOLITH-CuraMedix_Blog.png?width=300&name=MAGNETOLITH-CuraMedix_Blog.png)CuraMedix is committed to helping medical professionals integrate a range of innovative, evidence-based, non-surgical tools and technology to include [Extracorporeal Magnetotransduction Technology (EMTT)](https://www.curamedix.com/orthopedic-products/magnetolith) into their continuum of care. This enables them to broaden their treatment options and help patients get better faster without surgery, risk, or downtime. As one of the newest and most innovative technologies to treat chronic musculoskeletal diseases, EMTT is evidence-based, non-invasive, and an exceptional complement to EPAT/ESWT. Compared to other magnetic field technology, EMTT distinguishes itself due to its high oscillation frequency of 100 – 300 kHz. This feature allows for deeper penetration and a more comprehensive range of applications. **CuraMedix is thrilled to announce the launch of the new *****EMTT (Extracorporeal Magnetotransduction Technology) device, the MAGNETOLITH, powered by STORZ Medical.*** Initially, the first in the U.S. to hear of EMTT attended a conference last fall sponsored by [The Institute for Tissue Generation and Repair](https://www.theinstituteforregenmed.com/). Share in the excitement by watching this compelling webinar ["The Official U.S. Introduction to EMTT and the MAGNETOLITH Debut"](https://www.curamedix.com/webinar-the-official-us-introduction-to-emtt-and-the-magnetolith-debut) featuring Dr. Ludger Gerdesmeyer.  ### ** Primary Indications for the Use of EMTT ** EMTT can be used to treat numerous musculoskeletal disorders and a variety of pain syndromes. This technology is backed by significant research, and has shown to be extremely successful in the regeneration and rehabilitation of complicated conditions. Look with confidence to Extracorporeal Magnetotransduction Technology to treat the dysfunctions listed below:  - ******Degenerative joint disorders****** - ***Wear and tear conditions*** such as osteoarthritis (knees, hips, hands, shoulders, elbows), herniated discs, spondylarthrosis - ***Pain treatment*** - Chronic pain, for example, back pain, lumbago, tension, radiculopathy - ***Sports injuries*** - Chronic inflammation of tendons and joints, tendon overuse syndromes, inflammation of the pubic bone  - ******Relaxation of muscle spasms****** - ***Prevention or retardation of disuse atrophy ***to temporarily increase local blood circulation in healthy leg muscles - ***Immediate post-surgical stimulation of calf muscles*** to prevent venous thrombosis - ******Maintaining or improving range of motion****** - ***Temporary relief of pain associated with sore and aching muscles*** in the: – Shoulder – Waist – Upper extremities – Lower extremities ### ** 9 Noteworthy Benefits of Using EMTT ** With the introduction of EMTT, a new magnetic field technology, medical professionals will be able to offer patients a superior tissue-healing technology that provides a more comfortable and streamlined experience. Patients will find that treatment with [the MAGNETOLITH system](https://www.curamedix.com/orthopedic-products/magnetolith) is painless for the patient and easy for the medical professional to administer. The clear advantages of using EMTT include the following: 1. Evidence-based 2. Non-invasive  3. Wide range of applications 4. Outpatient procedure 5. No need to remove clothing 6. No side effects 7. Easy to use 8. High level of patient comfort 9. An excellent complement to EPAT/ESWT ### **Spotlight on Facts, Figures, and MAGNETOLITH Parameters** Please note that while EMTT relies on a different operating mechanism than ESWT does, the two modalities are highly effective when used together. Consider the value of these two exceptional treatments: EPAT/ESWT acts using high-energy acoustic/physical signals in a local treatment area, while EMTT acts using high-energy electromagnetic radiation in a regional treatment area. Here are the highlights on EMTT: - High oscillating frequency with high penetration depth (100 – 300 kHz) - The device offers continuous and reliable operation by a water-cooled applicator - Simple plug in and plug out to change the applicator - Integrated touch display to adjust energy level, frequency, and pulse rate - Flexible holding arm and one locking knob for easy positioning - Effectivity and safety are proven in studies   | **MAGNETOLITH PARAMETERS** | | | --- | --- | | Oscillation frequency | 130 kHz | | Oscillations per pulse | >15 | | Maximum field strength (at the coil) | 0.6 T | | Magnetic field strength (4cm distance from the coil) | 60 mT | | Performance of the magnetic field (dB max/dt) | 65.300 T/s | ### **4 Studies That Highlight the Significant Effects of This Magnetic Field Technology** There is tremendous value in clinical data when it comes to new technology. EMTT is a revolutionary magnetic field technology backed by science. The articles and evidence listed below offer insight into the significant therapeutic effects of using EMTT devices.  *Some of the information contained in the articles listed may pertain to products, indications for use of products and/or treatments/ procedures that are only available outside the United States and have not been approved or cleared for marketing by the United States Food & Drug Administration. * [Electromagnetic Transduction Therapy And Shockwave Therapy in 86 Patients With Rotator Cuff Tendinopathy: A Prospective Randomized Controlled Trial](https://pubmed.ncbi.nlm.nih.gov/30183430/) appeared in *Electromagnetic Biology and Medicine (2018)* [Electromagnetic Transduction Therapy in Non-Specific Low Back Pain: A Prospective Randomised Controlled Trial ](https://pubmed.ncbi.nlm.nih.gov/28736490/)published in *Journal of Orthopaedics (2017)* [Electromagnetic Transduction Therapy for Achilles Tendinopathy: A Preliminary Report on a New Technology](https://pubmed.ncbi.nlm.nih.gov/28842106/) in *The Journal for Foot and Ankle Surgery (2017)* [Electromagnetic Transduction Therapy in Patients with Chronic Aseptic Osteitis Pubis](https://gavinpublishers.com/assets/articles_pdf/1539686849article_pdf1741691410.pdf) inside the *Journal of Orthopedic Research and Therapy 2018 * ### **Be Among the First to Add EMTT to Your Continuum of Care** As a medical professional, it's vital to have the latest medical technology to provide best in class care to your patients. Here's what one world-renowned physician says about this latest breakthrough technology. *"The MAGNETOLITH, using high-end, non-invasive EMTT technology, is a potent tissue healing stimulator on various musculoskeletal tissue to include bones, tendons, muscles, joints, and fascia. In combination with focused shockwave and radial pressure wave, evidence-based EMTT appears to be a highly effective partner lifting my tissue healing expectations to another level; and this, after over 500 treatments using the MAGNETOLITH, without any apparent risk in the young, the older, and the advanced athletes.”* — Dr. Karsten Knobloch, MD Interested in learning more and discussing this unique opportunity? [Contact us](https://www.curamedix.com/contact-us) to continue the conversation. Or [view the EMTT webinar presented by Dr. Ludger Gerdesmeyer to learn more.](https://www.curamedix.com/webinar-the-official-us-introduction-to-emtt-and-the-magnetolith-debut) Topics: [Research](https://www.curamedix.com/blog/tag/research), [EMTT](https://www.curamedix.com/blog/tag/emtt) - [Tweet](https://twitter.com/share) #### Subscribe to Our Blog Stay in the loop! Get the latest research, peer insights, and helpful tips for your practice delivered to your inbox. ### Posts by Topic - [EPAT (97)](https://www.curamedix.com/blog/tag/epat) - [ESWT (93)](https://www.curamedix.com/blog/tag/eswt) - [EMTT (72)](https://www.curamedix.com/blog/tag/emtt) - [shockwave (68)](https://www.curamedix.com/blog/tag/shockwave) - [Research (47)](https://www.curamedix.com/blog/tag/research) - [Practice Improvement (19)](https://www.curamedix.com/blog/tag/practice-improvement) - [Practice Profiles (19)](https://www.curamedix.com/blog/tag/practice-profiles) - [Tradeshows and Events (13)](https://www.curamedix.com/blog/tag/tradeshows-and-events) - [Level 10 Research (9)](https://www.curamedix.com/blog/tag/level-10-research) - [Marketing (9)](https://www.curamedix.com/blog/tag/marketing) - [Orthopedics (8)](https://www.curamedix.com/blog/tag/orthopedics) - [Industry News (7)](https://www.curamedix.com/blog/tag/industry-news) - [Patient Communication (6)](https://www.curamedix.com/blog/tag/patient-communication) - [shock wave (6)](https://www.curamedix.com/blog/tag/shock-wave) - [AWT (5)](https://www.curamedix.com/blog/tag/awt) - [Aesthetics (5)](https://www.curamedix.com/blog/tag/aesthetics) - [EPAT Myths (4)](https://www.curamedix.com/blog/tag/epat-myths) - [Wound (4)](https://www.curamedix.com/blog/tag/wound) - [PR (3)](https://www.curamedix.com/blog/tag/pr) - [Webinars (3)](https://www.curamedix.com/blog/tag/webinars) - [Neuropathy (2)](https://www.curamedix.com/blog/tag/neuropathy) - [Biologics (1)](https://www.curamedix.com/blog/tag/biologics) - [Veterinary (1)](https://www.curamedix.com/blog/tag/veterinary) [see all](https://www.curamedix.com/blog/emtt-for-musculoskeletal-disorders#) ### Recent Posts ### NEWSLETTERS - [October 2022](https://www.curamedix.com/hubfs/October%202022%20Newsletter.png) - [September 2022](https://www.curamedix.com/hubfs/September%202022%20Newsletter.png) - [August 2022](https://www.curamedix.com/hubfs/August%202022%20Newsletter.png) - [July 2022](https://www.curamedix.com/hubfs/July%202022%20Newsletter.png) - [June 2022](https://www.curamedix.com/hubfs/June%202022%20-%20Newsletter.png) - [May 2022](https://www.curamedix.com/hubfs/May%202022%20-%20Newsletter.png) - [April 2022](https://www.curamedix.com/hubfs/April%202022%20-%20Newsletter.png) - [March 2022](https://www.curamedix.com/hubfs/March%202022%20-%20%20Newsletter.png) - [February 2022](https://www.curamedix.com/hubfs/February%202022%20-%20Newsletter.png) - [January 2022](https://www.curamedix.com/hubfs/January%202022%20-%20Newsletter.png) - [November 2021](https://www.curamedix.com/hubfs/November%202021%20-%20Newsletter.png) - [October 2021](https://www.curamedix.com/hubfs/October%202021%20-%20Newsletter.png) - [September 2021](https://www.curamedix.com/hubfs/Prospect%20Newsletters%20PDF/September%202021%20-%20Newsletter.pdf) - [August 2021](https://www.curamedix.com/hubfs/Prospect%20Newsletters%20PDF/August%202021%20Newsletter.pdf) - [July 2021](https://www.curamedix.com/hubfs/Prospect%20Newsletters%20PDF/July%202021%20Newsletter.pdf) - [June 2021](https://www.curamedix.com/hubfs/Prospect%20Newsletters%20PDF/June%202021%20Newsletter.pdf) - [May 2021](https://www.curamedix.com/hubfs/May%202021%20Newsletter.pdf) - [April 2021](https://www.curamedix.com/hubfs/April%202021%20Newsletter.pdf) - [March 2021](https://www.curamedix.com/hubfs/Prospect%20Newsletters%20PDF/March%20Newsletter%202021.pdf) - [February 2021](https://www.curamedix.com/hubfs/Prospect%20Newsletters%20PDF/February%202021%20Newsletter.pdf) - [January 2021](https://www.curamedix.com/hubfs/Prospect%20Newsletters%20PDF/January%202021%20Newsletter.pdf) - [December 2020](https://www.curamedix.com/hubfs/Prospect%20Newsletters%20PDF/December%202020%20Newsletter.pdf) - [November 2020](https://www.curamedix.com/hubfs/Prospect%20Newsletters%20PDF/November%202020%20Newsletter.pdf) - [October 2020](https://www.curamedix.com/hubfs/October%202020%20-%20Newsletter.pdf) [![Asset 7](https://www.curamedix.com/hs-fs/hubfs/Asset%207.png?width=271&name=Asset%207.png "Asset 7")](https://www.curamedix.com/) Subscribe to Our Newsletter Timely tips and valuable insights for better clinical and economic outcomes for your practice Connect With Us | [** ](https://twitter.com/curamedix) |   | [** ](https://www.facebook.com/CuraMedix-234400296629284/) |   | [** ](https://www.linkedin.com/company/curamedix/) |   | [** ](https://www.youtube.com/@CuraMedix_) | | --- | --- | --- | --- | --- | --- | --- | Corporate Headquarters 40 Albion Road Lincoln, RI 02865 [877.699.8399](tel:8776998399) ©2026 CuraMedix. All rights reserved  | [Disclaimer](https://www.curamedix.com/disclaimer)  | [Privacy Policy](https://www.curamedix.com/privacy-policy) ![](https://px.ads.linkedin.com/collect/?pid=2436618&fmt=gif)